124 related articles for article (PubMed ID: 36333906)
1. Multi-Targeting Nano-Systems Targeting Heterogeneous Cancer Cells for Therapeutics and Biomarker Detection.
Ren XH; Han D; He XY; Guo T; Chen XS; Pang X; Cheng SX
Adv Healthc Mater; 2023 Feb; 12(4):e2202155. PubMed ID: 36333906
[TBL] [Abstract][Full Text] [Related]
2. Detection of mRNAs of Ribosomal Protein L15 and E-Cadherin in Living Circulating Tumor Cells at Single Cell Resolution To Study Tumor Heterogeneity.
Xu C; He XY; Ren XH; Han D; Cheng SX
Anal Chem; 2022 Aug; 94(30):10610-10616. PubMed ID: 35856393
[TBL] [Abstract][Full Text] [Related]
3. Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level.
Ren XH; He XY; Xu C; Han D; Cheng SX
Adv Sci (Weinh); 2022 Jul; 9(21):e2105806. PubMed ID: 35595716
[TBL] [Abstract][Full Text] [Related]
4. A Multiple Targeting Nanoprobe for Identifying Cancer Metastatic Sites Based on Detection of Various mRNAs in Circulating Tumor Cells.
Han D; Ren XH; Liao XR; He XY; Guo T; Chen XS; Pang X; Cheng SX
Nano Lett; 2023 May; 23(9):3678-3686. PubMed ID: 37052638
[TBL] [Abstract][Full Text] [Related]
5. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
7. Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers.
Gao T; Ding P; Li W; Wang Z; Lin Q; Pei R
Nanoscale; 2020 Nov; 12(44):22574-22585. PubMed ID: 33174555
[TBL] [Abstract][Full Text] [Related]
8. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
10. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
11. Optical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell.
Hwang JY; Kim ST; Han HS; Kim K; Han JS
Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27886058
[TBL] [Abstract][Full Text] [Related]
12. Novel Peptide-Based Magnetic Nanoparticle for Mesenchymal Circulating Tumor Cells Detection.
Jia F; Wang Y; Fang Z; Dong J; Shi F; Zhang W; Wang Z; Hu Z
Anal Chem; 2021 Apr; 93(14):5670-5675. PubMed ID: 33788544
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
14. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
Brown TC; Sankpal NV; Gillanders WE
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
[TBL] [Abstract][Full Text] [Related]
15. Glucometer Readout for Portable Detection of Heterogeneous Circulating Tumor Cells in Lung Cancer Captured on a Dual Aptamer Functionalized Wrinkled Cellulose Hydrogel Interface.
Zuo Y; Lu W; Xia Y; Meng J; Zhou Y; Xiao Y; Zhu L; Liu D; Yang S; Sun Y; Li C; Yu Y
ACS Sens; 2023 Jan; 8(1):187-196. PubMed ID: 36562728
[TBL] [Abstract][Full Text] [Related]
16. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells.
Eslami-S Z; Cortés-Hernández LE; Alix-Panabières C
Cells; 2020 Aug; 9(8):. PubMed ID: 32764280
[TBL] [Abstract][Full Text] [Related]
17. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
18. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
[TBL] [Abstract][Full Text] [Related]
19. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.
Vila A; Abal M; Muinelo-Romay L; Rodriguez-Abreu C; Rivas J; López-López R; Costa C
PLoS One; 2016; 11(10):e0163705. PubMed ID: 27711186
[TBL] [Abstract][Full Text] [Related]
20. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
